| Literature DB >> 32784859 |
Nemi Malhotra1, Oliver B Villaflores2, Gilbert Audira3,4, Petrus Siregar4, Jiann-Shing Lee5, Tzong-Rong Ger1,6, Chung-Der Hsiao3,4,6.
Abstract
Graphene and its oxide are nanomaterials considered currently to be very promising because of their great potential applications in various industries. The exceptional physiochemical properties of graphene, particularly thermal conductivity, electron mobility, high surface area, and mechanical strength, promise development of novel or enhanced technologies in industries. The diverse applications of graphene and graphene oxide (GO) include energy storage, sensors, generators, light processing, electronics, and targeted drug delivery. However, the extensive use and exposure to graphene and GO might pose a great threat to living organisms and ultimately to human health. The toxicity data of graphene and GO is still insufficient to point out its side effects to different living organisms. Their accumulation in the aquatic environment might create complex problems in aquatic food chains and aquatic habitats leading to debilitating health effects in humans. The potential toxic effects of graphene and GO are not fully understood. However, they have been reported to cause agglomeration, long-term persistence, and toxic effects penetrating cell membrane and interacting with cellular components. In this review paper, we have primarily focused on the toxic effects of graphene and GO caused on aquatic invertebrates and fish (cell line and organisms). Here, we aim to point out the current understanding and knowledge gaps of graphene and GO toxicity.Entities:
Keywords: fish; graphene; graphene oxide; invertebrates; toxicity
Mesh:
Substances:
Year: 2020 PMID: 32784859 PMCID: PMC7465277 DOI: 10.3390/molecules25163618
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Potential application of graphene-based nanomaterials in industrial and biomedical fields. The graphene-based nanomaterials are widely applied for producing sensor, electronic, drug targeting, 3D bioprinting, construction, antimicrobial agents, supercapacitor, and light processing.
Summary of graphene and graphene oxide (GO) toxicity in aquatic animals.
| Animal | Route of Graphene Exposure | Adverse Outcome | Dosage Concentration and Time | Ref. |
|---|---|---|---|---|
| Tested in invertebrate species | ||||
|
| Waterborne exposure | Short-term GO exposures can induce oxidative stress, epithelial inflammation, and adversely affect overall | 1 and 10 mg/L 72 h static renewal. | [ |
|
| Waterborne exposure | Elevated lipid peroxidation and changes in glutathione-s-transferase (GST) activities were observed in gills and digestive gland tissues of the GO-exposed oysters. Oxidative damage, stress signaling leading to adverse effects on cellular health. | 2.5 and 5 mg/L 14 days | [ |
|
| Waterborne exposure | GO induced negative effects on the regenerative capacity, altered energy-related responses, especially glycogen content, and decrease in metabolism, cellular damage in | 0.01, 0.10 and 1.00 mg/L 28 days | [ |
|
| Waterborne exposure | GO induced significant toxicity to | 50.0, 65.0, 84.5, 110.0 and 143.0 mg/L 21 days | [ |
|
| Waterborne exposure | 14C-labeled graphene accumulated 1% of the organism dry mass. Excretion of graphene at constant phase in depuration. Addition of algae and humic acid to water during the depuration period resulted in release of a significant fraction (~90%) of the accumulated graphene, some remained in the organism. Accumulated graphene in adult | 250, 100, 50 and 25 µg/L 48 h | [ |
|
| Waterborne exposure | GO induced lethality, reproduction inhibition, ROS generation, reduction on feeding rates and accumulation on gut tract. There was a shift in the available energy for self-maintenance rather than feeding or reproduction activities. | Acute exposure: 0.1; 0.2; 0.4; 0.8; 1.6 and 3.2 mg/ L, 48 h | [ |
|
| Waterborne exposure | GO did not present acute ecotoxicity at concentrations up to 5.0 mg/L. The 96 h LC50 of Cd associated with GO was 1.7 times less than the 96 h LC50 of Cd alone and the 96 h LC50 of Zn associated with GO was 1.8 times less than the 96 h LC50 of Zn alone. The co-exposure of GO with trace elements impaired the routine metabolism of | GO - 0.1; 1.0; 2.5 and 5.0 mg/L 96 h | [ |
|
| Waterborne exposure | Significant decrease in RBC count. No significant effect on WBC, PCV, and Hb. | 0, 10, 20 mg/L, 10 days | [ |
| Tested in fish cell lines | ||||
| PLHC-1 | Co-exposure - increasing concentration of AhR agonist alone or in presence of GO and CXYG. | GO and CXYG had potentiating effect on PAH- and PCB-induced Cyp1A expression at both the transcriptional and the enzymatic levels. It suggested surface chemistry of GO and CXYG did not had influence on the direct or indirect interaction with the selected AhR agonists. The obtained results suggest that a preceding and/or simultaneous exposure to GO or CXYG nanoplatelets may modify the toxicokinetics of aromatic environmental pollutants such as PAHs and PCBs. | GO and carboxyl graphene (CXYG) at 16 µg/mL, AhR agonist. | [ |
| PLHC-1 | α-MEM medium | PLHC-1 cells demonstrated significantly reduced mitochondrial membrane potential (MMP) and increased ROS levels at 16 μg/mL GO and CXYG (72 h), but barely any decrease in cell viability. The observation of intracellular graphene accumulations not enclosed by membranes suggests that GO and CXYG internalization in fish hepatoma cells occurs through an endocytosis-independent mechanism. | GO: 0.125–16 µg/mL; CXYG: 0.25–32 µg/mL | [ |
| BF2 | GO in milli Q water (stock solution) + Eagle’s medium | GO caused mitochondrial and lysosomal damage to BF-2 cells, oxidative stress, and morphological changes by GO through ROS, as indicated by the evaluated biomarkers LPO, GSH, SOD, CAT, and 8-OHdG. | 0, 10, 20, 40, 60, 80 and 100 μg/mL for 24 h | [ |
| PLHC-1 and CLC | GRMs – Carbon nanofibers (CNFs) and graphene oxide (GO) | GO sheets were present within vesicles as well as free in the cytoplasm of both cell types. CNFs toxicity was inversely related to the graphitization degree. | 0–200 μg /mL of GRMs for 24 and 72 h | [ |
| Tested at embryonic or larvae stages of fish | ||||
|
| Waterborne exposure | Hatching delay of zebrafish embryos at a high dosage of 50 mg/L. Embryos exposed to GO exhibited significant cellular apoptosis only in the forehead and eye region, and no aggravation of cellular apoptosis was observed with increasing concentration of GO. | 0, 3.4, 7.6, 12.5, 25 and 50 mg/L | [ |
|
| Waterborne exposure | GO impaired DNA modification, protein carbonylation, ROS generation (also superoxide radical) | 1–100 µg/L | [ |
| Waterborne exposure | GO translocated from the water to the brains of parental and offspring fish with a significant loss of | GO exposed to parental zebrafish 24 h prior mating 0.01–1 μg/L | [ | |
|
| Waterborne exposure | Regardless of the presence of HA, larvae exposed to GO for 5 days showed an increase in locomotor activity, reduction in the yolk sac size, and total length and inhibition of AChE activity, but there was no difference in enzyme expression. Results indicated that HA is associated with the toxicity risk modulation by GO. | GO-100 mg/L & HA 20 mg/L alone or together for 5–7 days | [ |
|
| Waterborne exposure | GO adhered to and enveloped the chorion of zebrafish embryos mainly via hydroxyl group interactions, blocked the pore canals of the chorionic membrane, and caused marked hypoxia and hatching delay. | 0, 0.01, 0.1, 1, 100 mg/L for 24, 48 and 96 hpf | [ |
|
| Waterborne exposure of GO, Humic Acid (HA) and GO-HA | GO induced significant cardiac edema and hatching delay. | GO 0–100 mg/L | [ |
| Injections at ventral end of larvae | GO induced hepatic dysfunction through the ROS and PPAR-α mediated innate immune signaling in zebrafish | 0, 0.25, 0.5, and 1 mg/L for 72 h | [ | |
|
| Waterborne exposure of GO and reduced graphene (rGO) | GO had significant effects on the heart rate, while rGO affected the embryos hatching and the length of larvae in a dose-dependent manner | 1, 5, 10, 50, 100 mg/L for 96 h | [ |
|
| Waterborne exposure | GO induced cardiac and dopaminergic alterations, as well as neuronal gene expression and morphology modifications. Altered locomotion in terms of increase of turn angle suggesting parkinsonian-like motor symptoms (at low concentrations). | 5, 10, 50 or 100 mg/L for 6 days | [ |
|
| Waterborne exposure | GOs induced oxidative stress and apoptosis. In particular, the immune cell number, pro-inflammatory iNOS activity, and AChE activity (a neural development indicator) were found to be induced to some extent after GO exposure, suggesting the presence of both immunomodulatory and neurotoxic effects in zebrafish larvae. The waterborne-GO exposure on zebrafish during early development was not merely dependent on GO concentration but also the associated GO sizes. | GO particles (50–200 nm, <500 nm, and >500 nm) at 0.1, 1, 10, and 100 mg/L for 4–124 h post-fertilization | [ |
|
| Microinjection (4 nL/embryo) | Graphene induced no significant locomotion alterations, sleep behavior, and gene expression patterns. | Graphene at 1, 10, 50 µg/mL | [ |
| Tested at adult stage of fish | ||||
|
| Waterborne exposure | GO caused toxicity-Oxidative stress and tissue damage induced in fish by GO through ROS, indicated by the biomarkers of MDA, GSH, SOD, and CAT; GO caused immunotoxicity in fish indicated by increased expression of inflammatory cytokines, TNF-, IL-1, and IL-6. | 0, 1, 5, 10 or 50 mg/L GO for 14 days | [ |
|
| Carbon 14 labeled few-layered graphene (FLG) | At 48 h larger FLG (L-FLG) at 250 µg/L the amount of graphene was close to 48 mg/kg fish dry mass, 170-fold greater than body burden of the same concentration of smaller FLG (S-FLG). L-FLG accumulated in gut and S-FLG accumulated in gut and liver. L-FLG and S-FLG had significantly different impact on intestinal microbial community structure. | L-FLG- 300–700 nm | [ |
|
| Graphene family materials (GFMs), Monolayer graphene powder (GR), graphene oxide nanosheet (GO), reduced graphene oxide powder (rGO) | GFMs led to different inflammatory responses and significantly altered the relative composition of the gut bacterial species. | 1 µg in fish diet for 21 days | [ |
|
| Waterborne exposure | GO caused increase in oxidative stress, increase in lipid peroxidation, changes in SOD, CAT, GPx. After 168 h: GO toxic effects decreased, but homeostasis not fully recovered. | 2, 10, and 20 mg/L | [ |
|
| Injection at base of caudal fin | GO induced oxidative stress in cell and mitochondria in fish | 200 µL from 1 g/L | [ |
Figure 2Current understanding of the potential toxicity induced by graphene-based nanomaterials graphene, graphene oxide, reduced graphene, and few-layer graphene are listed in the top panel (green color) in fish cells, invertebrates, embryo, and adult aquatic organisms. The common-used in vitro and in vivo aquatic animal models are listed in the middle panel (yellow color). The potential cytotoxicity induced by graphene-based nanomaterials is summarized in the bottom panel (pink color).
Figure 3Comparison of paper publication number related to aquatic toxicity induced by three carbon-based nanomaterials during the past 16 years (from 2004 to 2020). Papers relevant to graphene-based nanomaterials are highlighted with blue color. Papers relevant to fullerene-based nanomaterials are highlighted with red color. Papers relevant to carbon nanotube are highlighted with green color.